Lek associates make corporate citizenship part of their everyday work
Lek associates in the field of Biomedicine took part in an interesting educational project which has a significant corporate citizenship component. As part of an educational program called Communication in Teams and Team Games they assembled children’s bicycles, which they then donated to the Ljubljana Moste – Polje Association of Friends of Youth, or more precisely to their Vila (Fairy) holiday home in Kranjska Gora. In doing so they once again demonstrated that corporate citizenship is part of Lek’s everyday operations.
Lek, a Sandoz company endeavors to create a healthy work environment and a good workplace atmosphere. The activities designed for the associates therefore also include team-building educational courses. Since socially responsible operations is an important value for Lek associates, they decided as part of their education to work in teams to assemble three children’s bicycles, which they accomplished with a great deal of cooperation and coordination. At the same time, the training course was conducted in accordance with Sandoz and Novartis’ guidelines on diversity and the inclusion of associates in Lek’s operations.
Team-building course with a charity flavor
Biomedicine is a small but heterogeneous area at Development Center Slovenia. The associates at Biomedicine perform important tasks in which they all have to excel, despite their differences. This can only be achieved through good cooperation among all of the members of the team. Therefore, Dr. Maja Jenko Osel MD, Head of Biomedicine at Lek is particularly proud of the associates’ success in the bicycle building project: “I think that all of the participants at this course learned quite a few things about communicating more effectively in a team. Also, the decision to replace the adrenaline rush that these courses usually have with a charity theme, and do something good for the people around us, turned out to be an excellent one. With the holidays and gift-giving coming up, we thought about children who couldn’t afford bikes because of their social marginalization. This offers children a lot of childhood pleasure and despite their differences offers each of them inclusion in children’s play, and at the same time orients them towards healthy lifestyles. We think that they will be happy with our gift.”
Bikes for kids who go on holiday at the Vila holiday home
The high point of the team-building course, which was held at the Hotel Lek in Kranjska Gora, was the donation of the three bikes to the Vila holiday home, which is run by the Ljubljana Moste – Polje Association of Friends of Youth. Upon accepting the donated bicycles, Anita Ogulin, Secretary of the Ljubljana Moste – Polje Association of Friends of Youth and President of the Humanitarian Affairs Committee of the Slovenian Association of Friends of Youth, said: ”Ever increasing numbers of parents are turning to the Ljubljana Moste – Polje Association of Friends of Youth and requesting various forms of assistance. We see the greatest amount of difficulties during the holidays. Parents do not have the money to send their children on holiday. Therefore we are opening the doors to our holiday homes even wider. We are truly happy to receive the donated bicycles. At the Vila holiday home in Kranjska Gora, many children will be able to take shorter and longer rides around Kranjska Gora. We put “ear to ear smiles”on the faces of children who join us at various camps and vacations during the holidays and on weekends. Therefore we sincerely thank Lek for this recreational equipment which will make children with limited opportunities happy and help them develop their skills!”
Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. Its role within Sandoz is to act as: a global development center for products and technologies; a global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar products; and, a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and Commonwealth of Independent States (CIS), and it is responsible for sales on the Slovenian market. For further information please visit http://www.lek.si/eng/.
Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of approximately 1000 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany), Eon Labs (US), EBEWE Pharma (Austria) and Oriel Therapeutics (US). In 2009, Sandoz employed around 23,000 people worldwide and posted sales of USD 7.5 billion. For further information please visit www.sandoz.com.
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group’s continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit www.novartis.com
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For further information contact:
Katarina Klemenc Dinjaški
Lek Pharmaceuticals d.d.
Phone: + 386 1 580 22 43
Fax: + 386 1 580 24 32